Washington, November 17 (RHC)-- U.S. President Donald Trump has nominated Alex Azar, a former top executive of pharmaceutical giant Eli Lilly, to lead the Department of Health and Human Services. The post has been vacant since the resignation of Tom Price.
Public Citizen’s Robert Weissman criticized the nomination, saying: “Tom Price supported Big Pharma in the U.S. Congress. Now apparently Trump has decided to cut out the middleman and let a pharmaceutical executive literally run the federal department that protects the health of all Americans.”
Donald Trump Nominates Former Drug Company Executive as HHS Secretary
Facebook
Twitter
Pinterest
Telegram
Linkedin
WhatsApp
Related Articles
Commentaries
MAKE A COMMENT
All fields required
More Views
- U.S. lawmakers propose withdrawing from United Nations, saying it no longer serves Washington's interests
- Brazil announces dates for BRICS summit
- Thousands take part in London rally against Donald Trump’s Gaza ownership plan
- Venezuelan government reveals terrorist plans dismantled before January 10th swearing-in of President Nicolas Maduro
- Cuban president congratulates new head of African Union Commission
